Table 4.
Feature | Outcome: Death from PCa | ||
---|---|---|---|
HR | 95% CI | p value | |
Log PSA before SRP, ng/m | 1.85 | 1.32–2.60 | <0.001 |
| |||
Biopsy Gleason score before SRP | |||
≤6 | Reference | Reference | 0.04 |
7 | 4.14 | 1.12–15.40 | – |
≥8 | 8.09 | 2.25–29.10 | – |
Unknown/not graded | 4.03 | 1.16–14.00 | – |
| |||
Clinical stage before SRP | |||
T1 | Reference | Reference | 0.03 |
T2 | 5.81 | 0.78–43.40 | – |
T3 | 10.60 | 1.39–80.60 | – |
Unknown | 1.74 | 0.16–19.30 | – |
| |||
Pathology Gleason score at SRP | |||
≤6 | Reference | Reference | 0.003 |
7 | 0.68 | 0.20–2.22 | – |
≥8 | 3.43 | 1.22–9.64 | – |
Unknown/not graded | 1.87 | 0.67–5.20 | – |
| |||
EPE | 1.67 | 0.85–3.28 | 0.14 |
| |||
SVI | 2.22 | 1.17–4.21 | 0.015 |
| |||
LNI | 1.30 | 0.60–2.84 | 0.5 |
| |||
PSM | 1.80 | 0.96–3.37 | 0.068 |
PCa = prostate cancer; PSA = prostate-specific antigen; SRP = salvage radical prostatectomy; CI = confidence interval; EPE = extraprostatic extension; SVI = seminal vesical invasion; LNI = lymph node involvement; PSM = positive surgical margins.